Insider filing · TWST
Emily M. Leproust
Chief Executive Officer
profile →
Twist Bioscience Corporation
TWST · Healthcare · 110 filings in 24 months
ticker →
Emily M. Leproust sold $2.5M of Twist Bioscience (TWST)
Executed Aug 12, disclosed Aug 14, 2 days later.
Value, as filed
$2.5M
19,952 sh × $125.08
Executed
Aug 12
the trade date, as filed
Disclosed
Aug 14
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ELEmily M. Leproust (Chief Executive Officer) filed 21 Form 4 reports in the trailing twelve months (0 purchases, 21 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $56.3M of TWST (356,546 sh across 13 lots, as filed), executed Sep 17.
The name
TWSTHealthcare · Twist Bioscience Corporation manufactures and sells synthetic DNA-based products
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Emily M. Leproust in TWST
TWSTSALE
Twist Bioscience Corporation
$619K4,573 sh × $135.40
Exec Nov 3
Filed Nov 5 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $575K
2,857 sh across 2 lots
Exec Oct 5
Filed Oct 7 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $8.8M
46,391 sh across 2 lots
Exec Oct 1
Filed Oct 5 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $279K
1,687 sh × $165.49
Exec Sep 21
Filed Sep 23 · 4:07 PM ET TWSTSALE Twist Bioscience Corporation $56.3M
356,546 sh across 13 lots
Exec Sep 17
Filed Sep 21 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $6.3M
41,570 sh across 5 lots
Exec Aug 25
Filed Aug 27 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $923K
6,639 sh × $139.07
Exec Aug 21
Filed Aug 25 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $14.2M
113,318 sh × $125.16
Exec Aug 10
Filed Aug 12 · 4:05 PM ET